The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury

Bhurint Siripanthong1, Babken Asatryan2, Thomas C Hanff3

  • 1School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Insights

Coronavirus disease (COVID-19) can cause heart damage through direct viral effects or indirect immune responses. Preliminary findings suggest potential long-term cardiac issues and rare post-vaccination myocarditis, particularly in young males.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Coronavirus disease 2019 (COVID-19) is associated with myocardial injury.
  • Mechanisms include direct viral invasion and indirect cellular damage via hypercoagulability and immune responses.
  • Preliminary data indicate potential long-term structural and functional cardiac changes in affected patients.

Purpose of the Study:

  • To summarize the mechanisms of COVID-19-related myocardial injury.
  • To highlight preliminary findings on long-term cardiac consequences.
  • To note the occurrence of myocarditis following COVID-19 vaccination.

Main Methods:

  • Review of existing literature and preliminary clinical data.
  • Analysis of reported cases of COVID-19 cardiac involvement.
  • Examination of data on post-vaccination myocarditis.

Main Results:

  • COVID-19 can lead to myocardial fibrosis, edema, and intraventricular thrombi.
  • Functional changes include left ventricular enlargement, reduced ejection fraction, and arrhythmias.
  • Post-vaccination myocarditis is rare but observed more frequently in young males.

Conclusions:

  • COVID-19 poses risks for myocardial injury with potential for lasting cardiac effects.
  • Further large-scale prospective studies are needed to validate these early findings.
  • Understanding these cardiac implications is crucial for patient management and public health.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
73
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
50
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
38